Literature DB >> 8258511

Characteristics of frequency-of-seeing curves in normal subjects, patients with suspected glaucoma, and patients with glaucoma.

B C Chauhan1, J D Tompkins, R P LeBlanc, T A McCormick.   

Abstract

PURPOSE: The authors performed this study to determine factors that affect the characteristics of frequency-of-seeing curves in normal subjects, patients with suspected glaucoma, and patients with glaucoma.
METHODS: The sample consisted of 70 subjects (22 normal subjects, 12 patients with suspected glaucoma, and 36 patients with glaucoma). A program was written to interface with the Humphrey Field Analyzer (Humphrey Instruments, San Leandro, CA) to measure frequency-of-seeing curves. The authors presented stimuli 8 dB either side of the estimated threshold in 1-dB intervals with five repetitions at each stimulus intensity. The authors tested four to six locations in each subject, with randomization of the stimulus intensity and location. Fixation was monitored with the Heijl-Krakau method. Using a probit program, the authors calculated the threshold and slope (estimated by the interquartile range) of each curve.
RESULTS: The authors obtained 124 curves from the normal subjects, 71 from the patients with suspected glaucoma, and 183 from the patients with glaucoma. In all three groups, the slope of the frequency-of-seeing curve was correlated highly with the threshold or threshold deviation, although the correlation was significantly higher in the normal subjects compared with the patients with suspected glaucoma and patients with glaucoma, even after controlling for the range of the threshold and threshold deviation. For this reason, the authors found considerably different frequency-of-seeing curves, between subject groups and also within the group of patients with glaucoma, in locations with the same threshold.
CONCLUSIONS: There may be fundamental differences in areas of normal subjects and patients with glaucoma with similar thresholds or threshold deviations. These differences also may exist within patients with glaucoma.

Entities:  

Mesh:

Year:  1993        PMID: 8258511

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  31 in total

1.  Measurement error of visual field tests in glaucoma.

Authors:  P G D Spry; C A Johnson; A M McKendrick; A Turpin
Journal:  Br J Ophthalmol       Date:  2003-01       Impact factor: 4.638

2.  Normal visual field test results following glaucomatous visual field end points in the Ocular Hypertension Treatment Study.

Authors:  John L Keltner; Chris A Johnson; Richard A Levine; Juanjuan Fan; Kimberly E Cello; Michael A Kass; Mae O Gordon
Journal:  Arch Ophthalmol       Date:  2005-09

3.  Pupillary evaluation of retinal asymmetry: development and initial testing of a technique.

Authors:  Yanjun Chen; Harry J Wyatt; William H Swanson
Journal:  Vision Res       Date:  2005-09       Impact factor: 1.886

4.  Detecting ocular-visual function changes in diabetes.

Authors:  C A Westall
Journal:  Br J Ophthalmol       Date:  2005-11       Impact factor: 4.638

5.  Development and evaluation of a linear staircase strategy for the measurement of perimetric sensitivity.

Authors:  Rizwan Malik; William H Swanson; David F Garway-Heath
Journal:  Vision Res       Date:  2006-06-09       Impact factor: 1.886

6.  Ganglion cell loss and age-related visual loss: a cortical pooling analysis.

Authors:  Pauline M Pearson; Laura A Schmidt; Emily Ly-Schroeder; William H Swanson
Journal:  Optom Vis Sci       Date:  2006-07       Impact factor: 1.973

Review 7.  Detection of visual field progression in glaucoma with standard achromatic perimetry: a review and practical implications.

Authors:  Kouros Nouri-Mahdavi; Nariman Nassiri; Annette Giangiacomo; Joseph Caprioli
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2011-08-26       Impact factor: 3.117

8.  Comparison of regression models for serial visual field analysis.

Authors:  Jun Mo Lee; Kouros Nouri-Mahdavi; Esteban Morales; Abdelmonem Afifi; Fei Yu; Joseph Caprioli
Journal:  Jpn J Ophthalmol       Date:  2014-08-28       Impact factor: 2.447

Review 9.  Detection and measurement of clinically meaningful visual field progression in clinical trials for glaucoma.

Authors:  C Gustavo De Moraes; Jeffrey M Liebmann; Leonard A Levin
Journal:  Prog Retin Eye Res       Date:  2016-10-20       Impact factor: 21.198

10.  A two-stage neural spiking model of visual contrast detection in perimetry.

Authors:  S K Gardiner; W H Swanson; S Demirel; A M McKendrick; A Turpin; C A Johnson
Journal:  Vision Res       Date:  2008-07-21       Impact factor: 1.886

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.